On September 5th, MGI and Qi-biodesign announced a strategic partnership to formally introduce the MGI DNBSEQ-G99 sequencer, the BGI Sequencer nanopore sequencer, etc. The two parties will combine their respective advantages to carry out more extensive cooperation in data analysis methods, protein optimization and microbial data sharing of high-throughput sequencers to promote revolutionary breakthroughs in new gene editing tool enzymes and delivery technologies, and further realize the independent control of new gene editing technologies.

Dr. Kevin Zhao, Co-founder and CTO of Qi-biodesign, and Peng Huanhuan, Vice President and General Manager of China Region of MGI, signed the strategic cooperation agreement on behalf of both parties.

Peng Huanhuan said: “As a creator of core tools in life science technology, MGI has always adhered to the innovative research and development of ‘read-write-stored’ tools. With this cooperation with Qi-biodesign, MGI hopes to explore more possibilities in the field of gene editing with our partners, to facilitate scientific research and industrial progress in the agricultural field, and to contribute to the development of the life science technology industry.”

Dr. Kevin Zhao said: “We are very pleased to join hands with MGI, from ‘independently controllable’ tools to ‘blooming’ applications. Qi-biodesign and MGI have many similarities in their development. We look forward to accelerating the R&D cycle, reducing R&D costs, and speeding up the transformation of applications through our cooperation, to aid in biotechnological breeding and achieve the revitalization of the national seed industry.”

Qi-biodesign is committed to developing independently controllable new precision gene-editing technologies and creating excellent biological traits and products. MGI is dedicated to providing the industry with advanced core tools of life science technology. It is one of the few companies in the world that can independently research and develop and mass-produce clinical-grade gene sequencers with different throughputs from Gb to Tb levels. In this cooperation, the DNBSEQ-G99 will serve as the high-throughput sequencing equipment in the laboratory, playing a significant role in gene editing data such as editing efficiency, genotyping, and tool enzyme mining in the development of gene-editing tools. It will greatly improve data efficiency, shorten the R&D cycle, and effectively reduce R&D costs.